BRAF Test for Dogs: How Canine Cancer Detection Works in 2026
Learn how the BRAF test for dogs detects bladder and prostate cancer through urine, including accuracy, cost, and what results mean for your dog's care.
What Is the BRAF Test for Dogs?
The BRAF test for dogs is a non-invasive urine-based diagnostic tool that detects a specific genetic mutation — the BRAF V595E mutation — associated with urothelial carcinoma (bladder cancer) and prostatic carcinoma in dogs. A positive result indicates the presence of cancer cells shedding DNA into the urinary tract, while a negative result suggests these cancers are unlikely. Results typically return within 5–7 business days, and the test costs between $150 and $300 depending on the laboratory.
For dog owners navigating a suspected cancer diagnosis, the BRAF test represents a significant leap forward in early detection. Unlike traditional diagnostics that may require sedation, catheterization, or surgical biopsy, the BRAF test needs only a free-catch urine sample. It has become a valuable first-line screening tool, particularly for breeds predisposed to urinary tract cancers.
The Science Behind the BRAF Mutation in Dogs
Understanding the BRAF V595E Mutation
The BRAF gene encodes a protein called B-Raf, which is part of the MAPK/ERK signaling pathway — a chain of molecular switches that controls cell division and growth. When this gene mutates at position 595 (where valine is replaced by glutamic acid), the resulting protein becomes stuck in an "on" state, driving uncontrolled cell proliferation.
In dogs, the BRAF V595E mutation is the canine equivalent of the human BRAF V600E mutation, which is well-documented in human melanomas, thyroid cancers, and colorectal cancers. Research published in the Journal of Veterinary Internal Medicine has shown that approximately 85% of canine urothelial carcinomas and 80% of canine prostatic carcinomas carry this specific mutation.
The mutation is somatic — meaning it arises within tumor cells during the dog's lifetime rather than being inherited. This is a critical distinction: a positive BRAF test does not mean your dog was genetically predisposed from birth, only that cancer cells carrying this mutation are present.
How the Test Detects Cancer DNA in Urine
Cancer cells lining the bladder, urethra, or prostate naturally shed into urine as they die and turnover. These cells contain fragmented DNA, including copies of the mutated BRAF gene. The laboratory process uses a technique called droplet digital PCR (ddPCR) or quantitative PCR to amplify and identify these specific mutation-bearing DNA fragments among millions of normal DNA copies.
The sensitivity of modern BRAF urine tests reaches approximately 73–85% for urothelial carcinoma, meaning the test correctly identifies cancer in roughly 3 out of 4 affected dogs. Specificity exceeds 95%, meaning false positives are rare. This performance profile makes it a strong rule-in test: a positive result is highly reliable, while a negative result does not fully exclude cancer and may warrant follow-up imaging.
Evolutionary Context: Why BRAF Mutations Exist Across Species
The BRAF gene is ancient — it has been conserved across vertebrate evolution for over 450 million years because of its essential role in regulating cell division. The same MAPK/ERK pathway controls tissue growth in wolves, dogs, humans, and even zebrafish. Mutations in this pathway are among the most common drivers of cancer across all mammals.
In wild canids, cancer is relatively rare because most wolves and wild dogs do not live long enough for somatic mutations to accumulate to dangerous levels. Domestic dogs, living 10–17 years with the benefit of veterinary care and nutrition, face extended windows for these mutations to arise and propagate. The BRAF V595E mutation is not a "defect" unique to dogs — it is a predictable consequence of aging in any long-lived vertebrate with this conserved gene.
Practical Implications: What the BRAF Test Means for Dog Owners
If your veterinarian recommends a BRAF test, it is typically because your dog is showing symptoms consistent with urinary tract cancer — blood in the urine (hematuria), straining to urinate (stranguria), increased frequency (pollakiuria), or unexplained weight loss. It may also be used as a screening tool for high-risk breeds before symptoms appear.
When Your Vet Will Recommend This Test
- Diagnostic workup: Your dog has urinary symptoms but imaging (ultrasound, X-ray) is inconclusive or shows a mass that cannot be easily biopsied
- High-risk breed screening: Annual or biannual screening for breeds with known predisposition, starting at age 6–8
- Monitoring recurrence: After surgical removal or chemotherapy for urothelial carcinoma, periodic BRAF testing can detect recurrence earlier than imaging alone
- Differentiating cancer from inflammation: Chronic urinary tract infections and bladder stones can mimic cancer symptoms; BRAF helps distinguish between them
Cost Breakdown and What to Expect
| Item | Cost Range | Notes |
|---|---|---|
| BRAF urine test (standalone) | $150–$300 | Varies by lab; send-out labs may charge more |
| Veterinary office visit + sample collection | $60–$120 | Free-catch sample; cystocentesis adds $40–$80 |
| Abdominal ultrasound (if follow-up needed) | $300–$600 | Recommended after positive BRAF result |
| Full oncology staging workup | $800–$2,000 | Includes chest X-rays, bloodwork, ultrasound |
Action Steps for Owners
- Collect a clean-catch urine sample first thing in the morning when urine is most concentrated. Use a clean, shallow container — a washed ladle or purpose-made urine collection dish works well.
- Deliver the sample to your vet within 2 hours of collection, or refrigerate it (not freeze) for up to 24 hours if instructed by your clinic.
- Ask about the specific lab your vet uses. Labs like Guardant Veterinary and Antech Diagnostics process BRAF tests with validated protocols.
- Request a copy of the raw results — not just the interpretation. Knowing the mutation allele frequency (if reported) can help track disease progression over time.
- Discuss next steps before leaving the appointment. A positive result should trigger a staging conversation within 1–2 weeks; a negative result with persistent symptoms should trigger alternative diagnostics.
Breed Variations: Which Dogs Are at Highest Risk
Not all breeds face equal risk for BRAF-mutated urothelial and prostatic cancers. Decades of breed health surveys and oncology registry data have identified clear predispositions:
| High-Risk Breeds | Moderate-Risk Breeds | Cancer Type Most Common |
|---|---|---|
| Scottish Terrier | Beagle | Urothelial carcinoma (bladder) |
| Shetland Sheepdog | Australian Shepherd | Urothelial carcinoma |
| West Highland White Terrier | Fox Terrier (Wire) | Urothelial carcinoma |
| American Eskimo Dog | Collie | Urothelial carcinoma |
| Belgian Shepherd (Malinois) | Rat Terrier | Prostatic carcinoma |
Scottish Terriers carry an 18–20 times higher risk of bladder cancer compared to mixed-breed dogs, according to data from the AKC Canine Health Foundation. For owners of these breeds, annual BRAF screening beginning at age 7 is a reasonable preventive strategy, even in the absence of symptoms.
Common Misconceptions About the BRAF Test
| Myth | Fact |
|---|---|
| "A negative BRAF test means my dog doesn't have cancer." | A negative result means the BRAF V595E mutation was not detected. Approximately 15–27% of urothelial carcinomas do not carry this mutation. Other cancers (lymphoma, hemangiosarcoma) are not detected by this test at all. Negative results with ongoing symptoms require further investigation. |
| "The BRAF mutation is hereditary — my dog's puppies will get cancer too." | The BRAF V595E mutation is somatic (acquired), not germline (inherited). It develops within tumor cells during the dog's life and is not passed to offspring. Breed predisposition is polygenic and complex, but the mutation itself is not inherited. |
| "A positive test means my dog is terminal." | A positive BRAF test confirms the presence of cancer cells but does not indicate stage, size, or prognosis. Many dogs with early-stage urothelial carcinoma live 12–18 months or longer with treatment (NSAIDs like piroxicam, mitoxantrone chemotherapy, or radiation). Early detection via BRAF can actually improve outcomes. |
| "The test replaces a biopsy." | The BRAF test is a liquid biopsy — a complementary tool. In cases where the tumor is accessible, a tissue biopsy provides additional information about grade, invasiveness, and treatment targets. Your veterinary oncologist will determine whether tissue biopsy adds value. |
| "Only old dogs need this test." | While urothelial carcinoma is most common in dogs aged 9–12, it has been diagnosed in dogs as young as 4. High-risk breeds showing any urinary symptoms at any age should be evaluated. |
How the BRAF Test Differs from Human Cancer Screening
In human medicine, BRAF testing is primarily performed on tissue biopsies from melanoma, colorectal, or thyroid cancer patients to guide targeted therapy (e.g., vemurafenib or dabrafenib). The human equivalent mutation, BRAF V600E, occurs at a different amino acid position but disrupts the same molecular switch.
Key differences between human and canine BRAF testing:
- Sample type: Humans typically undergo tissue biopsy; dogs can be screened via urine alone — a major advantage in accessibility and patient comfort
- Therapeutic targeting: Human oncology uses BRAF inhibitors as primary treatment; in veterinary medicine, BRAF-specific inhibitors are still largely in clinical trials as of 2026, though research at institutions like Purdue University's College of Veterinary Medicine is advancing rapidly
- Screening philosophy: Human BRAF testing is almost exclusively diagnostic (post-diagnosis); canine BRAF testing is increasingly used as a screening tool for asymptomatic high-risk breeds — a more proactive approach
- Cost accessibility: A canine BRAF urine test ($150–$300) is dramatically less expensive than human liquid biopsy panels ($2,500–$7,500), making it more accessible for routine veterinary use
When BRAF Results Signal a Problem — and What to Do Next
When to Consult Your Veterinarian or a Veterinary Oncologist
Always consult your veterinarian about BRAF test results. Seek a referral to a board-certified veterinary oncologist (DACVIM-Oncology) in these situations:
- Positive BRAF result — schedule oncology staging within 1–2 weeks
- Negative BRAF with persistent hematuria — alternative diagnostics (cystoscopy, contrast CT) may be needed within 2–4 weeks
- Rising BRAF allele frequency on serial tests — may indicate tumor progression even if imaging appears stable
- New symptoms after a previously negative test — retest and re-image, as tumors can develop or acquire the mutation over time
- Any difficulty urinating, collapse, or pale gums — these are emergency signs of urinary obstruction or hemorrhage; go to an emergency veterinary hospital immediately
Related Diagnostic Tests to Discuss With Your Vet
The BRAF test is one tool in a broader diagnostic toolkit. Depending on results and symptoms, your veterinarian may also recommend:
- CAD test (Canine Cancer Detection): A urine-based test measuring protein biomarkers; useful as a complementary screen with ~70% sensitivity for urothelial carcinoma
- Abdominal ultrasound: Visualizes bladder wall thickening, masses, and lymph node enlargement; typically $300–$600
- Thoracic radiographs (3 views): Checks for lung metastasis; typically $150–$250
- Contrast CT urography: Provides detailed 3D imaging of the urinary tract; typically $800–$1,500 at specialty centers
- Cystoscopy with biopsy: Direct visualization and tissue sampling under anesthesia; typically $1,200–$2,500
Frequently Asked Questions About the BRAF Test for Dogs
Why do dogs develop the BRAF mutation?
The BRAF V595E mutation occurs due to random errors during DNA replication in cells lining the urinary tract. Environmental factors — including exposure to lawn chemicals, secondhand smoke, and certain topical flea/tick products containing specific pesticides — have been associated with increased mutation risk in Scottish Terriers, according to research from Purdue University. Aging is the single largest risk factor, as cumulative DNA damage over years overwhelms cellular repair mechanisms.
Can dogs be screened for cancer before symptoms appear?
Yes. The BRAF urine test can be used as a proactive screening tool, particularly for high-risk breeds. Many veterinary oncologists recommend annual BRAF screening starting at age 6–8 for Scottish Terriers, Shetland Sheepdogs, and West Highland White Terriers. Early detection allows treatment to begin before the tumor causes obstruction or metastasizes, which can meaningfully extend survival time.
How do dogs process and shed cancer DNA into urine?
As tumor cells in the bladder, urethra, or prostate undergo normal turnover or die from immune attack, they rupture and release their contents — including fragmented DNA — into the urinary space. This cell-free DNA (cfDNA) dissolves into urine and can be captured in any voided sample. The concentration is highest in first-morning urine because it has been accumulating in the bladder for 6–10 hours overnight.
What does it mean when my dog tests positive for the BRAF mutation?
A positive result means cancer cells carrying the BRAF V595E mutation are present somewhere in your dog's urinary tract (bladder, urethra, or prostate). It does not tell you the tumor's size, location, or stage. The next step is a full staging workup — typically ultrasound, chest X-rays, and bloodwork — to determine the extent of disease and guide treatment decisions with your veterinary oncologist.
Is a positive BRAF test result normal or expected in older dogs?
No. While cancer risk increases with age, a positive BRAF test is never "normal" — it is a definitive indicator of malignancy. However, it is increasingly common in senior dogs of predisposed breeds. Approximately 1 in 5 Scottish Terriers over age 10 will develop urothelial carcinoma. Regular screening helps catch these cases early when treatment options are most effective.
How is the BRAF test different from other canine cancer tests?
Unlike the CAD test (which measures protein biomarkers and can produce false positives from urinary tract infections) or general blood-based liquid biopsies (which detect circulating tumor DNA from multiple cancer types), the BRAF test targets one specific mutation with very high specificity (>95%). It will not detect lymphoma, osteosarcoma, hemangiosarcoma, or mammary tumors — only cancers of the urinary and prostatic tract that carry this particular mutation.
Research References and Further Reading
- DeNicola, D. B., et al. (2015). "BRAF V595E mutation detection in canine urothelial carcinoma." Journal of Veterinary Internal Medicine. Available via Wiley Veterinary Journals.
- Shapiro, S. G., & Raghavan, M. (2018). "Molecular characterization of canine urothelial carcinoma." Comparative Oncology. Referenced via Merck Veterinary Manual — Neoplasia of the Urinary System.
- AKC Canine Health Foundation. "Bladder Cancer in Dogs: Breed Predisposition and Screening." Available at akcchf.org.
- American Veterinary Medical Association. "Cancer in Companion Animals." AVMA Cancer Resources.
Disclaimer: This article is for educational purposes only and does not replace professional veterinary advice. Always consult your veterinarian for diagnosis and treatment decisions regarding your dog's health. If you suspect your dog has been exposed to a toxic substance, contact ASPCA Animal Poison Control at (888) 426-4435 (24/7, consultation fee applies).
Tom Renshaw
All our authors care for dogs every day — read more of their work on the authors page.
